13/05/2026
Did you know Polycystic O***y Syndrome (PCOS) is increasingly being discussed under a new name: PMOS, PolyMetabolic O***y Syndrome?
The reason behind this shift is actually really important. For years, the term “Polycystic O***y Syndrome” has been considered misleading by many experts because:
• Not everyone with PCOS has ovarian cysts
• The condition affects far more than just the ovaries
• The name fails to reflect the major metabolic and hormonal components of the condition
Research has shown that PCOS is strongly linked to:
Insulin resistance
Chronic inflammation
Hormonal imbalance
Increased risk of Type 2 Diabetes
Cardiovascular risk factors
Fertility and ovulation issues
As medical understanding evolved, many researchers and clinicians felt the old name no longer matched the science.
That’s where “PMOS” comes in.
PolyMetabolic O***y Syndrome better reflects that this is a whole-body metabolic and endocrine condition, not simply an “ovary problem.”
Why does that matter?
Because names influence:
• How conditions are diagnosed
• How seriously symptoms are taken
• How treatment is approached
• How patients understand their own health
For many, the old terminology led to confusion, delayed diagnosis, or feeling dismissed, especially if they didn’t have visible ovarian cysts.
It’s important to note:
“PCOS” is still currently the most widely used and officially recognised medical term. PMOS is part of an ongoing discussion aimed at creating terminology that better reflects current science and patient experience.
Medicine evolves. Language evolves. And understanding this illness more accurately matters.
***ySyndrome
